Jagsonpal Pharmaceuticals Faces Increased Volatility Amid Broader Sector Declines

Jagsonpal Pharmaceuticals, a small-cap player in the Pharmaceuticals & Drugs sector, has experienced significant volatility today, with its stock price declining by 8.09% as of January 27, 2025. The stock underperformed its sector, which saw an overall decline of 2.42%, and has now recorded a consecutive drop over the last two days, totaling a loss of 13.55% during this period.
Despite opening the day with a gain of 3.44%, reaching an intraday high of Rs 249.3, the stock quickly reversed course, hitting a low of Rs 221, reflecting a notable intraday volatility of 6.15%. In terms of moving averages, the stock is currently positioned higher than its 100-day and 200-day averages but remains below its 5-day, 20-day, and 50-day averages.

Over the past month, Jagsonpal Pharmaceuticals has seen a decline of 12.32%, contrasting sharply with the Sensex, which has only fallen by 4.10%. This performance highlights the challenges faced by the company in the current market environment.